Dr. Amy Katherine Schulze, MD

Dr. Schulze practices at Christus St Vincent Breast Institute in Santa Fe, New Mexico.

Dr. Schulze's NPI, 1912430174, was assigned on April 5, 2017. Dr. Schulze graduated from Indiana University School of Medicine in 2017. Dr. Schulze holds Minnesota license 70794.

Dr. Schulze's primary practice is Christus St Vincent Breast Institute, at 490 W Zia Rd, Santa Fe, NM 87505 in Santa Fe County. The practice phone is (505) 913-3101.

Dr. Schulze's primary practice is Christus St Vincent Breast Institute in Santa Fe, New Mexico. Dr. Schulze is also affiliated with CHRISTUS St. Vincent Regional Medical Center. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Schulze to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schulze practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Schulze's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Schulze is licensed in Minnesota.

CMS data shows 214 Medicare services from Dr. Schulze across 4 procedure codes in 2024, for 88 Medicare patients. Medicare paid $17,174 for them. Every service was in an office.

CMS counts 88 Medicare patients who saw Dr. Schulze in 2024. The largest group is 65 to 74, with 48 patients. 70% of them have cancer, and 64% have high cholesterol. 14% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schulze's median patient age at 59, with 99% women.

In 2024, Dr. Schulze wrote 55 Medicare Part D claims for 36 patients. 100% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $47 in total drug cost. In 2019, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Schulze for performance year 2024, reported as part of a group. Dr. Schulze accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of mastectomy by Dr. Schulze, more than 68% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Schulze, published from 2020 to 2023. 2023 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Receptor, ErbB-2 and Biomarkers, Tumor. Dr. Schulze has published most often in Ann Surg Oncol. Dr. Schulze's most frequent co-authors are Judy C. Boughey, MD, Kazuaki Takabe, MD, PhD and Tina J. Hieken, MD.

CMS Open Payments shows 60 general payments to Dr. Schulze from 24 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 90% of the total. Sirius Medical Systems paid the most, $400.

Dr. Schulze graduated from Indiana University School of Medicine in 2017.